Q'Apel Medical Announces Appointment of Jay Hallinan
Q'Apel Medical has recently appointed Jay Hallinan as the Chief Commercial Officer, a seasoned professional in the medical device sector. With a strong background and two decades of experience, Hallinan is set to lead the global sales and marketing efforts of the company.
Leading Global Sales and Marketing Initiatives
In his new position, Hallinan will be responsible for shaping and executing Q'Apel's commercial strategy, focusing on revenue growth across their diverse product offerings. His extensive experience in the medical device environment prepares him well for this challenge.
Commitment to Growth and Innovation
"I am excited to join Q'Apel at this crucial time as the company looks to amplify its commercial activities," commented Hallinan. His previous roles included significant leadership positions that equipped him with the skills necessary to elevate both commercial execution and overall performance.
Experience and Expertise in the Industry
Before joining Q'Apel, Hallinan was the Vice President for North America at Stryker, where he significantly contributed to the company's market strategies and business development. His previous commercial roles at Stryker and leadership positions in companies like Boston Scientific and Medtronic add invaluable experience to his current role.
Impacting Neurovascular Interventions
Q'Apel Medical is dedicated to transforming neurovascular interventions. Hallinan’s joining during this vital period indicates the company’s ambition to enhance its impact in the neurovascular market. According to CEO Jodie Fam, Hallinan's proven track record in leadership will be instrumental as the company aims to expand its portfolio.
Setting a Vision for the Future
Hallinan aims to foster collaborations that enhance the existing team’s capabilities and build a foundation for future growth. "I look forward to working together," he expressed. His vision aligns well with Q'Apel’s commitment to addressing the challenging needs of clinicians involved in delicate procedures.
Innovative Solutions for Clinicians
Q'Apel Medical emphasizes its innovative and high-quality products, which are designed in consultation with neurovascular specialists. The company's approach seeks to tackle clinical challenges with solutions competitor firms may overlook.
About Q'Apel Medical
Q'Apel Medical is on a mission to revolutionize neurovascular interventions, creating products that meet current needs while being adaptable to future improvements. The company prides itself on its unique engineering and partnership with specialists to ensure the highest quality of care.
For more information about their products and initiatives, you can visit www.qapelmedical.com.
Media Contact:
Charlene Herndon
SPRIG Consulting
Frequently Asked Questions
Who is Jay Hallinan?
Jay Hallinan is the newly appointed Chief Commercial Officer at Q'Apel Medical, bringing over two decades of experience in the medical device industry.
What will Hallinan be responsible for at Q'Apel Medical?
He will oversee the global sales and marketing organization and drive the company’s commercial strategy and revenue growth.
What is Q'Apel Medical known for?
Q'Apel Medical focuses on innovating neurovascular interventions and developing solutions to meet clinicians’ challenges.
What experience does Hallinan have in the medical device industry?
He has extensive experience, including previous roles at Stryker, Boston Scientific, and Medtronic, along with being CEO of Tenex Health.
Why is the appointment of Hallinan significant?
His proven track record and leadership skills are expected to enhance Q'Apel's growth and position in the competitive neurovascular market.
